Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by SirStocksalot97on Nov 02, 2020 6:55pm
119 Views
Post# 31827082

RE:RE:RE:RE:RE:RE:Lost Some Weight

RE:RE:RE:RE:RE:RE:Lost Some WeightOne of the best posts you've made to date Master Jake. Thank you for your dedication to this stock!

Side note to reiterate an older post. This stock has the potential to hit the $1.50-$2.00 range, assuming buyout from a big player. For this to happen yes we do need sales. Units sold/leased with recurring revenue streams and reorders from hospitals will boost these figures. 80 units less approx. 20 units sold by year end leaves 60 tbs, over 12 months that's approx. 5 units a month. Doable so fingers still crossed, but never get your hopes up or get too attached to a stock!

SS
<< Previous
Bullboard Posts
Next >>